TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.

Eric S Christenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.